[investor.lilly.com] Most GLP-1 pens are dosed once weekly
Tirzepatide is already one of the most effective weight loss medications available, producing average losses of 15 to 20 percent of body weight in clinical trials
The available maintenance doses include: 5 mg once weekly 7.5 mg once weekly 10 mg once weekly 12.5 mg once weekly 15 mg once weekly (maximum approved dose) Dose escalation decisions should be individualized based on several factors, including weight loss response, tolerability of gastrointestinal side effects, and overall treatment goals
This can lead to greater improvements in blood sugar control and weight loss in comparison to other medications such as Ozempic and Wegovy, which only target GLP-1 receptors
The additional GIP receptor agonism may potentially further enhance insulin secretion and contribute to improved metabolic effects, though the exact mechanisms remain under investigation
A slightly less obvious day that gives you a better recovery window is almost always worth the minor inconvenience of setting a phone alarm
